| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Common Stock | Other | $1.34M | +655K | +1.42% | $2.05 | 46.7M | Jun 18, 2024 | See footnote. | F1, F2 |
| transaction | LAB | Common Stock | Other | $1.12M | +545K | $2.05 | 545K | Jun 18, 2024 | See footnote. | F3, F4 | |
| transaction | LAB | Common Stock | Other | -$2.46M | -1.2M | -100% | $2.05 | 0 | Jun 18, 2024 | See footnote. | F5, F6 |
| holding | LAB | Common Stock | 13.9M | Jun 18, 2024 | See footnote. | F7 | |||||
| holding | LAB | Common Stock | 104K | Jun 18, 2024 | Direct | F8 | |||||
| holding | LAB | Common Stock | 2.74M | Jun 18, 2024 | See footnote. | F9 | |||||
| holding | LAB | Common Stock | 3.77M | Jun 18, 2024 | See footnote. | F10 |
| Id | Content |
|---|---|
| F1 | Represents a cross-trade, pursuant to which Casdin Partners FO1-MSV, LP ("Casdin FO1") transferred 655,000 shares of Common Stock to Casdin Partners Master Fund, L.P. (the "Master Fund"). |
| F2 | The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP. |
| F3 | Represents a cross-trade, pursuant to which Casdin FO1 transferred 545,000 shares of Common Stock to Casdin Amplify Fund, LP ("Amplify"). |
| F4 | The securities are owned directly by Amplify and are deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Amplify, (ii) the GP, the general partner of Amplify, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. |
| F5 | Represents a cross-trade, pursuant to which Casdin FO1 transferred 1,200,000 shares of Common Stock to the Master Fund and Amplify. |
| F6 | The securities were owned directly by Casdin FO1 and were deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Casdin FO1, (ii) the GP, the general partner of Casdin FO1, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. |
| F7 | The securities are owned directly by Casdin Private Growth Equity Fund II, L.P. (the "Equity Fund II") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund II, and (ii) Eli Casdin, the managing member of Casdin. |
| F8 | The securities are owned directly by Eli Casdin. |
| F9 | The securities are owned directly by Casdin Private Growth Equity Fund, L.P. (the "Equity Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund, and (ii) Eli Casdin, the managing member of Casdin. |
| F10 | The securities are indirectly owned by Eli Casdin who has voting and investment discretion with respect to the securities. |
Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.